Obesitas fattness Obesity overweight severe obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (i) Completed a minimum of twelve months in formal lifestyle intervention and/or pharmacotherapy weight loss program; (ii) Age 13-17 with Tanner stage >= IV; (iii) Severe obesity meeting IFSO criteria for bariatric surgery, BMI >=40 kg/m2 with minor comorbidities or BMI >=35 kg/m2 with at least one major comorbidity, corrected for age and sex according to the IOTF criteria; (iv) Consensus in the multidisciplinary child obesity team, during the multidisciplinary meeting, on a strongly motivated participation of the participant during the lifestyle intervention program so far and in the future (after the bariatric surgery); the participant must have been fully committed to be successful in this program and is expected to continue with this effort after bariatric surgery; (v) Consensus in the multidisciplinary child obesity team on the diagnosis of non-responding to multidisciplinary lifestyle interventions for now and the near future.
Exclusion criteria
Exclusion criteria: - Unable to consent as appropriate; - Illiteracy (disability to read and understand questionnaires); - Secondary obesity, obesity caused by a medical condition; - Known syndrome (e.g. Prader-Willi syndrome); - Skeletal immaturity (Tanner stage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is a composite outcome: - Proportion of adolescents presented to the national board achieving 20% total weight loss (%TWL) 1 year after surgery; - Incidence of adverse health events and additional surgical intervention during 5 years follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes are: (i) Number of appointments per discipline and follow-up attendance during 5 years follow-up; (ii) Patient satisfaction at 1, 3 and 5 years after surgery and satisfaction of the multidisciplinary team members after 1, 3 and 5 years from start of the study; (iii) Perceived organization of care by the multidisciplinary team members after 1, 3 and 5 years from start of the study. (iv) Change in body weight, change in body mass index (BMI), %TWL and change in BMI standard deviation score during 5 years follow-up; (v) Prevalence and remission of obesity-related comorbidities during 5 years follow-up; (vi) Prevalence of cardio metabolic health parameters during 5 years follow-up; (vii) Bone health measures and incidence of bone fractures during 5 years follow-up; (viii) Quality of life, psychosocial health measures, and educational attainment at 1, 3 and 5 years after surgery; (ix) Body composition at 2 and 5 years after surgery. The secondary endpoints iv, v, vi and viii stated above will be used for this historical cohort as well. | — |
Countries
Netherlands